共 7 条
- [5] A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI) DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (02) : 63 - 71
- [6] Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia-related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity PROSTATE INTERNATIONAL, 2020, 8 (04) : 152 - 157